A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol

A double-blind placebo-controlled trial of azithromycin to reduce mortality and improve growth in high-risk young children with non-bloody diarrhoea in low resource settings: the Antibiotics for Children with Diarrhoea (ABCD) trial protocol

Abstract Background Acute diarrhoea is a common cause of illness and death among children in low- to middle-income settings. World Health Organization guidelines for the clinical management of acute watery diarrhoea in children focus on oral rehydration, supplemental zinc and feeding advice. Routine...

Full description

Bibliographic Details
Main Author: The ABCD study team
Format: Article
Language:English
Published: BMC 2020-01-01
Series:Trials
Subjects:
Antibiotics
Azithromycin
Paediatric diarrhoea
Mortality
Growth
Randomised
Online Access:https://doi.org/10.1186/s13063-019-3829-y

Internet

https://doi.org/10.1186/s13063-019-3829-y

Similar Items